Roche Stops RA Drug Development After Deaths
Pfizer Brings Out Big Guns to Woo Ratiopharm
AstraZeneca Shares Fall After Setback for Colon Cancer Drug
Xenoport, Inc., Restructures to Focus on Key Programs; Includes An Overall Reduction of 50% of XenoPort’s Workforce
Disciplined Physicians Used as ‘Drug Mouthpieces’ by Pharmaceutical Companies
Bald Women Lash Out at Sanofi-Avenits & Taxotere
Posted in Industry Stories
You must be logged in to post a comment.
SUBSCRIBE
SUBSCRIBE